BALYASNY ASSET MANAGEMENT L.P. - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 125 filers reported holding RIGEL PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$53,301
+56.8%
35,534
+22.2%
0.00%
Q3 2022$34,000
-26.1%
29,086
+87.8%
0.00%
Q1 2022$46,000
+76.9%
15,487
+34.5%
0.00%
Q4 2018$26,000
-89.1%
11,515
-83.0%
0.00%
-100.0%
Q1 2018$239,000
+368.6%
67,550
+236.1%
0.00%
Q3 2017$51,000
-96.3%
20,100
-94.6%
0.00%
-100.0%
Q3 2016$1,376,000
+3100.0%
375,000
+1842.6%
0.01%
Q2 2016$43,000
-46.2%
19,304
-49.8%
0.00%
Q1 2016$80,000
+73.9%
38,464
+151.0%
0.00%
Q4 2015$46,000
-68.3%
15,324
-76.0%
0.00%
-100.0%
Q4 2014$145,000
-87.9%
63,773
-89.7%
0.00%
-88.9%
Q3 2014$1,203,000
-68.5%
620,000
-53.7%
0.01%
-82.0%
Q4 2013$3,813,000
+7.2%
1,338,036
+34.6%
0.05%
+4.2%
Q3 2013$3,558,000
+77.6%
993,740
+65.7%
0.05%
+41.2%
Q2 2013$2,003,000599,7110.03%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 9,105,691$30,140,0005.99%
Sio Capital Management, LLC 1,888,181$6,250,0003.50%
DAFNA Capital Management LLC 473,478$1,567,0001.32%
Cormorant Asset Management, LP 2,000,000$6,620,0000.96%
Ghost Tree Capital, LLC 1,100,000$3,641,0000.68%
Rhenman & Partners Asset Management AB 1,282,000$4,243,0000.67%
Palo Alto Investors LP 4,254,623$14,083,0000.67%
NEA Management Company, LLC 3,243,150$10,375,0000.36%
Telemetry Investments, L.L.C. 170,000$563,0000.25%
NJ State Employees Deferred Compensation Plan 355,000$1,175,0000.22%
View complete list of RIGEL PHARMACEUTICALS INC shareholders